Stephen Gucker

Array ( [id] => 3695804 [patent_doc_number] => 05677135 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Method for increasing the resistance of neural cells to .beta.amyloid peptide toxicity' [patent_app_type] => 1 [patent_app_number] => 8/695923 [patent_app_country] => US [patent_app_date] => 1996-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 4666 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677135.pdf [firstpage_image] =>[orig_patent_app_number] => 695923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986482 [patent_doc_number] => 05910428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Brain-derived membrane-associated CRF binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/637761 [patent_app_country] => US [patent_app_date] => 1996-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13348 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910428.pdf [firstpage_image] =>[orig_patent_app_number] => 637761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7647305 [patent_doc_number] => 06476213 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Cloning and characterization of FLBA gene of H. pylori production of aflagellate' [patent_app_type] => B1 [patent_app_number] => 08/671757 [patent_app_country] => US [patent_app_date] => 1996-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22391 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476213.pdf [firstpage_image] =>[orig_patent_app_number] => 08671757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1409912 [patent_doc_number] => 06524789 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Human neuronal nicotinic acetylcholine receptor compositions and methods employing same' [patent_app_type] => B1 [patent_app_number] => 08/660451 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33750 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524789.pdf [firstpage_image] =>[orig_patent_app_number] => 08660451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940990 [patent_doc_number] => 05989920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5' [patent_app_type] => 1 [patent_app_number] => 8/668650 [patent_app_country] => US [patent_app_date] => 1996-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 47 [patent_no_of_words] => 51016 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989920.pdf [firstpage_image] =>[orig_patent_app_number] => 668650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301262 [patent_doc_number] => 06187548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Methods using human calcium sensor protein, fragments thereof and DNA encoding same' [patent_app_type] => 1 [patent_app_number] => 8/652877 [patent_app_country] => US [patent_app_date] => 1996-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 12 [patent_no_of_words] => 11322 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187548.pdf [firstpage_image] =>[orig_patent_app_number] => 652877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4229325 [patent_doc_number] => 06165469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kD subunit multigene family' [patent_app_type] => 1 [patent_app_number] => 8/569214 [patent_app_country] => US [patent_app_date] => 1996-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 13 [patent_no_of_words] => 24091 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165469.pdf [firstpage_image] =>[orig_patent_app_number] => 569214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694761 [patent_doc_number] => 05674328 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Dry tape covered laser shock peening' [patent_app_type] => 1 [patent_app_number] => 8/638622 [patent_app_country] => US [patent_app_date] => 1996-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 4602 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674328.pdf [firstpage_image] =>[orig_patent_app_number] => 638622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549681 [patent_doc_number] => 06399296 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Interaction trap systems for detecting protein interactions' [patent_app_type] => B1 [patent_app_number] => 08/630052 [patent_app_country] => US [patent_app_date] => 1996-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 14701 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399296.pdf [firstpage_image] =>[orig_patent_app_number] => 08630052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996061 [patent_doc_number] => 05919901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Neuropeptide Y receptor Y5 and nucleic acid sequences' [patent_app_type] => 1 [patent_app_number] => 8/630118 [patent_app_country] => US [patent_app_date] => 1996-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14374 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919901.pdf [firstpage_image] =>[orig_patent_app_number] => 630118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 732110 [patent_doc_number] => 07037647 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Prostate-specific membrane antigen and uses thereof' [patent_app_type] => utility [patent_app_number] => 08/894583 [patent_app_country] => US [patent_app_date] => 1996-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 130 [patent_figures_cnt] => 142 [patent_no_of_words] => 35375 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037647.pdf [firstpage_image] =>[orig_patent_app_number] => 08894583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013575 [patent_doc_number] => 05962664 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Psychosis protecting nucleic acid, peptides, compositions and method of use' [patent_app_type] => 1 [patent_app_number] => 8/602716 [patent_app_country] => US [patent_app_date] => 1996-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 17011 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962664.pdf [firstpage_image] =>[orig_patent_app_number] => 602716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536672 [patent_doc_number] => 20020137126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'AL-1 NEUROTROPHIC FACTOR, A LIGAND FOR AN EPH RELATED TYROSINE KINASE RECEPTOR' [patent_app_type] => new [patent_app_number] => 08/578684 [patent_app_country] => US [patent_app_date] => 1996-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26029 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137126.pdf [firstpage_image] =>[orig_patent_app_number] => 08578684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999216 [patent_doc_number] => 05986073 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Method for purifying somatotropin monomers' [patent_app_type] => 1 [patent_app_number] => 8/576517 [patent_app_country] => US [patent_app_date] => 1995-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6542 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986073.pdf [firstpage_image] =>[orig_patent_app_number] => 576517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772067 [patent_doc_number] => 05773588 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Method for purifying somatotropin monomers' [patent_app_type] => 1 [patent_app_number] => 8/566591 [patent_app_country] => US [patent_app_date] => 1995-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3326 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773588.pdf [firstpage_image] =>[orig_patent_app_number] => 566591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047034 [patent_doc_number] => 05968819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)' [patent_app_type] => 1 [patent_app_number] => 8/566096 [patent_app_country] => US [patent_app_date] => 1995-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 45 [patent_no_of_words] => 44879 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968819.pdf [firstpage_image] =>[orig_patent_app_number] => 566096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292952 [patent_doc_number] => 06197594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'White trigger preparations for improving the signal detection in bioluminescent and chemiluminescent reactions' [patent_app_type] => 1 [patent_app_number] => 8/552795 [patent_app_country] => US [patent_app_date] => 1995-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5810 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197594.pdf [firstpage_image] =>[orig_patent_app_number] => 552795 [rel_patent_id] =>[rel_patent_doc_number] =>)